Metabolism open最新文献

{"title":"Effect of vitamin D on risk of falls and fractures – The contribution of recent mega-trials","authors":"Bess Dawson-Hughes","doi":"10.1016/j.metop.2024.100300","DOIUrl":"10.1016/j.metop.2024.100300","url":null,"abstract":"<div><p>Three recently-completed, large clinical trials in the U.S, New Zealand, and Australia, referred to herein as the ‘mega-trials’, were conducted to determine the impact of supplemental vitamin D on a variety of outcomes including falls and fractures. The trials were similar in design and collectively included over 50,000 generally vitamin D replete, older men and women. The mega-trials established that vitamin D supplementation with the equivalent of 2000 to 3300 IU/d of vitamin D₃ had no favorable effect on risk of falls or fractures. This review focuses on specific design elements of the trials and how they likely influenced these trial findings. While these trials were in progress, evidence emerged that circulating 25-hydroxyvitamin D levels have a U-shaped association with risk of falling, raising concern about a potential untoward effect of high dose supplementation. There is compelling evidence that in older, vitamin D- and calcium-insufficient nursing home residents, the combination of vitamin D and calcium in modest replacement doses dramatically reduces the risk of hip and other fractures. Community-dwelling older adults in many populous countries around the globe have widespread vitamin D and calcium insufficiency. It is time to follow the evidence trail and determine the effect of vitamin D and calcium replacement on their risk of falls and fractures.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100300"},"PeriodicalIF":0.0,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S258993682400032X/pdfft?md5=465b81989f58807aa537e3f5f2347064&pid=1-s2.0-S258993682400032X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between APOE genotypes and metabolic syndrome in a middle aged and elderly Urban South Indian population","authors":"Shilna Azhuvalappil ,&nbsp;Raghav Prasad ,&nbsp;Pravin Sahadevan ,&nbsp;Priya Chatterjee ,&nbsp;Hitesh Pradhan ,&nbsp;Pooja Rai ,&nbsp;Anant Gupta ,&nbsp;Reddy Peera Kommaddi ,&nbsp;Thomas G. Issac ,&nbsp;Jonas S. Sundarakumar","doi":"10.1016/j.metop.2024.100301","DOIUrl":"10.1016/j.metop.2024.100301","url":null,"abstract":"<div><h3>Background</h3><p>This study examines the association between apolipoprotein E (APOE) genotypes and metabolic syndrome (MetS) in an older urban population in South India, as part of the Tata Longitudinal Study on Aging.</p></div><div><h3>Methods</h3><p>A total of 618 participants aged 45 and above were analyzed cross-sectionally for the association between APOE carrier status and MetS (based on both NCEP ATP III and Consensus criteria).</p></div><div><h3>Results</h3><p>Despite the high prevalence of MetS observed in this cohort (51.62 % by NCEP-ATP III and 61.33 % by Consensus criteria), multivariable logistic regression revealed no significant association between APOE genotypes and MetS under both criteria. However, specific associations were noted in age and sex-stratified analyses; notably, E2 carriers under 60 showed 0.42-fold decreased odds (95%CI:0.20,0.89, p-value-0.023) for an increased waist circumference, and E4 carriers above 60 were at 1.85 times increased odds (95 % CI:1.04,3.28, p-value&lt;0.05) for decreased HDL.</p></div><div><h3>Conclusion</h3><p>These findings suggest that while APOE genotypes influence certain metabolic parameters, their impact on MetS may be limited in this urban setting, possibly overshadowed by environmental factors and lifestyle influences, which was highlighted by the differences seen in its sister rural cohort.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100301"},"PeriodicalIF":0.0,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000331/pdfft?md5=4b4091c837908c2d495bb021de4051a4&pid=1-s2.0-S2589936824000331-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141706129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seasonal variation and Vitamin-D status in ostensibly healthy Indian population: An experience from a tertiary care institute","authors":"Karli Sreenivasulu ,&nbsp;Mithu Banerjee ,&nbsp;Sojit Tomo ,&nbsp;Kamalkant Shukla ,&nbsp;Maithili Karpaga Selvi ,&nbsp;Mahendra Kumar Garg ,&nbsp;Sumit Banerjee ,&nbsp;Praveen Sharma ,&nbsp;Ravindra Shukla","doi":"10.1016/j.metop.2024.100298","DOIUrl":"https://doi.org/10.1016/j.metop.2024.100298","url":null,"abstract":"<div><h3>Background</h3><p>25-hydroxy vitamin-D (25(OH)D) deficiency is prevalent worldwide including India. Earlier some cross-sectional studies have discussed 25(OH)D deficiency and its prevalence. The correlation of 25(OH)D with seasonal variation has been reported rarely in India. To determine the 25(OH)D levels and seasonal changes of 25(OH)D status at a tertiary care hospital in North-western India.</p></div><div><h3>Materials and methods</h3><p>25(OH)D assessments performed in laboratories between 2018 and 2020 was acquired using hospital records. A total of 11,428 assays of serum 25(OH)D were analyzed in the study. Subjects were divided into three groups based on the International Endocrine Society's recommendation for serum 25(OH)D level. The 25(OH)D deficiency &lt;20 ng/ml, insufficiency 20–29 ng/mL and sufficiency ≥30 ng/mL was defined. The months have been separated into the following seasons to analyze seasonal trends: Summer/monsoon (April–September), and winter/spring (October–March).</p></div><div><h3>Results</h3><p>The median 25(OH)D was 17.2 ng/mL. We observed the prevalence of 60 %, 24.1 % &amp; 15.9 % of 25(OH)D deficiency, 25(OH)D insufficiency, and sufficiency respectively in the total number of individuals tested. 56 % male and 63 % females were 25(OH)D deficient. Notably, the lowest median 25(OH)D value was found in the 21–30 age group (14.8 ng/mL). A significant difference in 25(OH)D levels between the summer (18.7 ng/mL) and winter (15.8 ng/mL) seasons has been noticed.</p></div><div><h3>Discussion</h3><p>Current study revealing that 25(OH)D deficiency is common in all age groups and genders, according to our findings. Surprisingly, the lowest levels were reported in young adults. Seasonal variation has an impact on 25(OH)D status, however in all seasons 25(OH)D levels are lower than reference intervals. These findings suggest that the criteria for determining the state of 25(OH)D insufficiency and deficiency in the Indian population should be reconsidered.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100298"},"PeriodicalIF":0.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000306/pdfft?md5=cf05258561852e455be66a27b50015ba&pid=1-s2.0-S2589936824000306-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141483916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adropin: A crucial regulator of cardiovascular health and metabolic balance","authors":"S. Rooban ,&nbsp;K.A. Arul Senghor ,&nbsp;V.M. Vinodhini ,&nbsp;J.S. Kumar","doi":"10.1016/j.metop.2024.100299","DOIUrl":"https://doi.org/10.1016/j.metop.2024.100299","url":null,"abstract":"<div><p>Adropin, a peptide discovered in 2008, has gained recognition as a key regulator of cardiovascular health and metabolic balance. Initially identified for its roles in energy balance, lipid metabolism, and glucose regulation, adropin has also been found to improve cardiovascular health by enhancing endothelial function, modulating lipid profiles, and reducing oxidative stress. These protective mechanisms suggest that adropin may be able to help prevent conditions such as atherosclerosis, hypertension, and other cardiovascular diseases. Research has established connections between adropin and cardiovascular risk factors, such as obesity, insulin resistance, and dyslipidemia, positioning it as a valuable biomarker for evaluating cardiovascular disease risk. New studies highlight adropin's diagnostic and prognostic significance, showing that higher levels are linked to better cardiovascular outcomes, while lower levels are associated with a higher risk of cardiovascular diseases. This review aims to summarize current knowledge on adropin, emphasizing its significance as a promising focus in the intersection of cardiovascular health and metabolic health. By summarizing the latest research findings, this review aims to offer insights into the potential applications of adropin in both clinical practice and research, leading to a deeper understanding of its role in maintaining cardiovascular and metabolic health.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100299"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000318/pdfft?md5=3a7014005f5cc0966d12437e6b0a19f2&pid=1-s2.0-S2589936824000318-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141483917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prescribing patterns of statins and associated factors among type 2 diabetes mellitus patients in Africa: A systematic review and meta-analysis","authors":"Worku Chekol Tassew ,&nbsp;Yeshiwas Ayale Ferede ,&nbsp;Agerie Mengistie Zeleke","doi":"10.1016/j.metop.2024.100297","DOIUrl":"https://doi.org/10.1016/j.metop.2024.100297","url":null,"abstract":"<div><h3>Background</h3><p>In sub-Saharan African nations, there's a documented shortfall in the utilization of statins, despite established clinical guidelines advocating their use for reducing cardiovascular risks and overall mortality among Type 2 diabetes patients aged 40–75 years old. Most clinical guidelines recommend prescribing statins to individuals with type 2 diabetes to reduce the chances of cardiovascular disease. There is currently a lack of extensive research on statin utilization specifically for primary prevention of cardiovascular disease in Africa. Thus, this study aimed to assess the prescription patterns of statins for preventing cardiovascular disease in type 2 diabetes patients.</p></div><div><h3>Methods</h3><p>The findings of the review were presented following the guidelines outlined in the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA-2020) checklist. We conducted searches on electronic databases including PubMed, EMBASE, Cochrane Library, Science Direct, African Journal Online, and Google Scholar. This systematic review and meta-analysis included articles that met specific inclusion criteria: observational studies such as cross-sectional, cohort, and case-control studies focusing on determinants, risk factors, or correlates associated with statin prescription within Africa. Only published articles up to June 2, 2024, published in English, and conducted in either community or healthcare facility settings were considered. Data import was initially conducted using Microsoft Excel, and statistical analysis was performed using STATA software. Cochran's Q test was employed to assess whether there was a significant variance in prevalence among the studies. Additionally, the I² statistic was utilized to quantify the extent of heterogeneity. A funnel plot, a visual tool, was utilized to evaluate publication bias.</p></div><div><h3>Results</h3><p>The search strategy resulted in 7695 published original articles. The full texts of the 89 papers were assessed for eligibility and quality. Moreover, some articles were rejected due to inaccuracies in the outcome variable. Ultimately, only ten studies focusing on the prevalence of statin prescription were examined. The research suggests that the pooled prevalence of statin prescription among Type 2 diabetic individuals in Africa is found to be 48.82% (95% CI: 35.41–63.24). Age greater than 65 years (AOR = 3.56, 95% CI: 1.70–7.45; I² = 54.7%), comorbidity (AOR = 1.13, 95% CI: 0.27–4.63, I² = 96.4%), dyslipidemia (AOR = 3.15, 95% CI: 1.54–6.44, I² = 61.7%), DM duration greater than ten years (AOR = 1.36, 95% CI: 0.81–2.28, I² = 77.3%), and government insurance (AOR = 8.85, 95% CI: 2.72–28.76, I² = 81.5%) were factors associated with statin prescription among type 2 diabetic patients.</p></div><div><h3>Conclusions</h3><p>In general, the extent of statin prescriptions for individuals with type 2 di","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100297"},"PeriodicalIF":0.0,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S258993682400029X/pdfft?md5=2d2dfa7844f60362bf3c33e03fa5e59e&pid=1-s2.0-S258993682400029X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141438978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"25-hydroxyvitamin D and parathyroid hormone in new onset sepsis: A prospective study in critically ill patients","authors":"Irene Karampela ,&nbsp;Theodora Stratigou ,&nbsp;Georgios Antonakos ,&nbsp;Dimitris Kounatidis ,&nbsp;Natalia G. Vallianou ,&nbsp;Dimitrios Tsilingiris ,&nbsp;Maria Dalamaga","doi":"10.1016/j.metop.2024.100296","DOIUrl":"https://doi.org/10.1016/j.metop.2024.100296","url":null,"abstract":"<div><p>Hypovitaminosis D is highly prevalent in critically ill patients, and it has been suggested to be a risk factor for infections, sepsis and higher mortality. We sought to investigate whether serum 25-hydroxyvitamin D (25(OH)D) and parathyroid hormone (PTH) in critically ill patients with new onset sepsis are associated with severity and outcome. We prospectively included 50 consecutive critically ill adult cases with new onset sepsis and 50 healthy controls matched for age and sex. PTH and 25(OH)D were determined in serum via electrochemiluminescence immunoassays at inclusion in the study in all cases and controls, and one week after sepsis onset in cases. Patients had reduced 25(OH)D compared to controls at sepsis onset (7.9 ± 3 vs 24.6 ± 6.7 ng/mL, p &lt; 0.001), whilst PTH was similar (median (range): 34.5 (5.7–218.5) vs 44.2 (14.2–98.1) pg/mL, p = 0.35). In patients, 25(OH)D upon enrollment and one week after did not differ significantly (7.9 ± 3 vs 7 ± 4.3 ng/mL, p = 0.19). All patients presented with hypovitaminosis D (25(OH)D &lt; 20 ng/mL), while 40 patients (80 %) had vitamin D deficiency (25(OH)D &lt; 12 ng/mL) at sepsis onset, including all ten (20 %) nonsurvivors, who died within 28 days from sepsis onset. Patients with sepsis (N = 28) and septic shock (N = 22) as well as survivors (N = 40) and nonsurvivors (N = 10) had similar 25(OH)D at enrollment (p &gt; 0.05). 25(OH)D was positively correlated with ionized calcium (r = 0.46, p &lt; 0.001) and negatively with PTH (p &lt; 0.05), while inflammatory biomarkers or the severity scores exhibited no correlation with 25(OH)D. Patients with septic shock and nonsurvivors had lower PTH than patients with sepsis and survivors respectively (42.2 ± 42.9 vs 73.4 ± 61.9 pg/mL, p = 0.04, and 18.3 ± 10.7 vs 69.9 ± 58.8 pg/mL, p = 0.001, respectively). C-reactive protein was negatively associated with PTH (r = −0.44, p = 0.001). In conclusion, vitamin D deficiency was present in 80 % of critically ill patients at sepsis onset, while nonsurvivors exhibited lower PTH than survivors. Additional, larger and multicenter studies are warranted to elucidate the contribution of vitamin D and PTH to the pathogenesis of sepsis and its outcomes.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100296"},"PeriodicalIF":0.0,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000288/pdfft?md5=e03d054fea77cabb55eec21157726239&pid=1-s2.0-S2589936824000288-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141333020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of associations between alcohol consumption and metabolic syndrome according to three definitions: The Swedish INTERGENE study","authors":"Alina Skultecka ,&nbsp;Fredrik Nyberg ,&nbsp;Lauren Lissner ,&nbsp;Maria Rosvall ,&nbsp;Dag S. Thelle ,&nbsp;Anna-Carin Olin ,&nbsp;Kjell Torén ,&nbsp;Lena Björck ,&nbsp;Annika Rosengren ,&nbsp;Kirsten Mehlig","doi":"10.1016/j.metop.2024.100292","DOIUrl":"10.1016/j.metop.2024.100292","url":null,"abstract":"<div><h3>Background</h3><p>While prevalence estimates differ by definition of metabolic syndrome (MetS), it is less clear how different definitions affect associations with alcohol consumption.</p></div><div><h3>Methods</h3><p>We included 3051 adults aged 25–77 from the baseline examination of the Swedish INTERGENE cohort (2001–2004). Using multiple logistic regression, we investigated cross-sectional associations between ethanol intake and MetS defined according to the Adult Treatment Panel III (ATP III), the International Diabetes Federation (IDF), and the Joint Interim Statement (JIS). Alcohol exposure categories comprised abstinence, and low, medium, and high consumption defined via sex-specific tertiles of ethanol intake among current consumers. Covariates included sociodemographics, health, and lifestyle factors.</p></div><div><h3>Results</h3><p>MetS prevalence estimates varied between 13.9 % (ATP III) and 25.3 % (JIS), with higher prevalence in men than women. Adjusted for age and sex, medium-high alcohol consumption was associated with lower odds of MetS compared to low consumption, while no difference was observed for abstainers. Only the most specific (and thus severe) definition of MetS (ATP III) showed decreasing odds for ethanol intake when adjusted for all covariates.</p></div><div><h3>Conclusion</h3><p>Our study shows that alcohol-related associations differ by definition of MetS. The finding that individuals with the most stringently defined MetS may benefit from alcohol consumption calls for further well-controlled studies.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"23 ","pages":"Article 100292"},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000240/pdfft?md5=5ae0a8d899fa1433ff6f3e96c1a28a63&pid=1-s2.0-S2589936824000240-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141392578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hydrogen sulfide derived from apoptotic cells supports immune homeostasis","authors":"Ying Xu,&nbsp;Suzhen Chen,&nbsp;Junli Liu","doi":"10.1016/j.metop.2024.100276","DOIUrl":"10.1016/j.metop.2024.100276","url":null,"abstract":"","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"22 ","pages":"Article 100276"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000082/pdfft?md5=d03603572055875b624c059bd677d9a4&pid=1-s2.0-S2589936824000082-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140469767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diet induced thermogenesis, older and newer data with emphasis on obesity and diabetes mellitus - A narrative review","authors":"Evangelia Tzeravini,&nbsp;Tentolouris Anastasios,&nbsp;Kokkinos Alexander,&nbsp;Tentolouris Nikolaos,&nbsp;Katsilambros Nikolaos","doi":"10.1016/j.metop.2024.100291","DOIUrl":"https://doi.org/10.1016/j.metop.2024.100291","url":null,"abstract":"<div><p>Obesity is a major public health problem with a prevalence increasing at an alarming rate worldwide. There is an urgent need for efficient approaches to weight management. Diet induced thermogenesis (DIT) is the process by which the body increases its energy expenditure in response to a meal. It is estimated to account for approximately 10 % of total energy expenditure and is considered a potentially modifiable component of energy expenditure. The palatability of food, meal's composition in macronutrients, the circadian rhythm and sleep, as well as individual's characteristics such as age, the presence of obesity or diabetes mellitus, and the proportion of physical activity are the main factors that affect DIT. However, studies examining DIT are mostly characterized by small sample size and the methodology varies considerably between studies. It seems that even today there is a lot of contradiction between the relative studies. Inspite of that, future research might lead to the modification of DIT in order to achieve some weight loss in obese people.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"22 ","pages":"Article 100291"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000239/pdfft?md5=8cefeda294d6573004b1fd2da1c9a27e&pid=1-s2.0-S2589936824000239-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141291955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beta cell-derived nanovesicle MicroRNAs promote insulin resistance","authors":"Ning Wang,&nbsp;Suzhen Chen,&nbsp;Junli Liu","doi":"10.1016/j.metop.2023.100266","DOIUrl":"10.1016/j.metop.2023.100266","url":null,"abstract":"","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"22 ","pages":"Article 100266"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936823000385/pdfft?md5=05551e8ca4bc520f14d15180e0f6bf66&pid=1-s2.0-S2589936823000385-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139015418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}